Maravai lifesciences completes acquisition of the dna and rna business of officinae bio

San diego--(business wire)--maravai lifesciences, inc. (nasdaq: mrvi), a global provider of life science reagents and services to researchers and biotech innovators, announced today that it has completed its previously announced acquisition of officinae bio's dna and rna business. this acquisition combines officinae bio's ai-enabled mrna design platforms with maravai and trilink biotechnologies' leading drug substance manufacturing capabilities, providing customers comprehensive expertise and n.
DNA Ratings Summary
DNA Quant Ranking